China has granted emergency use approval to a fifth Covid-19 vaccine which uses similar technology to vaccines against hepatitis B, whooping cough and flu. Photo: Handout
China has granted emergency use approval to a fifth Covid-19 vaccine which uses similar technology to vaccines against hepatitis B, whooping cough and flu. Photo: Handout

China’s production bottleneck ‘could be eased with latest Covid-19 vaccine’

  • Emergency use approval paves way for large-scale manufacture of cheap, easy-to-produce vaccines but three doses required
  • Non-peer reviewed clinical trial data suggests vaccine is well tolerated and produces immune response against the virus

Topic |   China science
China has granted emergency use approval to a fifth Covid-19 vaccine which uses similar technology to vaccines against hepatitis B, whooping cough and flu. Photo: Handout
China has granted emergency use approval to a fifth Covid-19 vaccine which uses similar technology to vaccines against hepatitis B, whooping cough and flu. Photo: Handout
READ FULL ARTICLE